IRF4 and glioblastoma: To further validate these findings, we investigated whether changes in the percentage positivity levels of BAT3, FOXO1, BLIMP1, and IRF4 intracellular proteins are observed in T and NK cells from glioblastoma patients compared to healthy controls.